ADAR and breast cancer: Even though, in BC, there is no direct link between ADAR1-mediated A>I(G) RNA editing and immunotherapy response, it has been described in other cancers that ADAR1 overexpression increases dsRNA editing in several cancers, decreasing their immunogenicity, and promoting tumor progression.